CE Unterberg initiates coverage on Corcept Therapeutics Inc. (Nasdaq: CORT) with a Buy rating and $10 price target. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE